ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY FOUNDATION (EIN 020464400) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1993

Legal Domicile

Principal Officer

EVANTHIA GALANIS MD

Phone

7737029171

Tax Period

2023-01-01 to 2023-12-31

ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY FOUNDATION, founded in 1993, is a mid-sized nonprofit in the Medical Research sector that reported $41.5M in total revenue in fiscal year 2023. Expenses of $40.0M left a modest 4% surplus.

Mission

THE FOUNDATION RAISES FUNDS TO HELP THE ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY ANSWER IMPORTANT TREATMENT QUESTIONS THROUGH LARGE-SCALE CLINICAL TRIALS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $15,688,073

Program Service Revenue $22,368,356

Investment Income $3,440,233

Other Revenue $3,424

TOTAL REVENUE $41,500,086

Expense Breakdown

Grants Paid $10,308,272

Salaries & Benefits $9,935,133

Fundraising Expenses $0

Program Expenses $31,414,393

Other Expenses $19,779,450

TOTAL EXPENSES $40,022,855

Year-over-Year Comparison

	2023	2022	Change
Revenue	$41,500,086	$39,386,118	+0.1%
Expenses	$40,022,855	$42,878,871	-0.1%
Net Income	$1,477,231	$-3,492,753	-1.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

101

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$375,460

Total Directors

$375,460

Key Employees

$256,288

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DHRUVA GOLLERKERI	TREASURER/CFO	30.00	Officer Director	$224,156	$35,304	$259,460
EVANTHIA GALANIS	PRESIDENT (AS OF NOV 2023)	0.75	Officer Director	$0	$0	$0
SUZANNE GEORGE	PRESIDENT (THRU NOV 2023)	0.75	Officer Director	$0	$0	$0
TRINIDAD AJAZI	SECRETARY	9.00	Officer Director	$116,000	$0	$116,000
OLWEN HAHN	VICE PRESIDENT/TRUSTEE	0.75	Officer Director	$0	$0	$0
TAREQ AL BAGHDADI	TRUSTEE	0.75	Director	$0	$0	$0
STEVEN ALBERTS	TRUSTEE	0.75	Director	$0	$0	$0
DANIEL ANDERSON	TRUSTEE	0.75	Director	$0	$0	$0
C BABIS ANDREADIS	TRUSTEE	0.75	Director	$0	$0	$0
JAMES ATKINS	TRUSTEE (THRU MAY 2023)	0.75	Director	$0	$0	$0
LYUDMILA BAZHENOVA	TRUSTEE	0.75	Director	$0	$0	$0
ROBERT BEHRENS	TRUSTEE (THRU MAY 2023)	0.75	Director	$0	$0	$0
ISABELLE BEDROSIAN	TRUSTEE	0.75	Director	$0	$0	$0
HAROLD BURSTEIN	TRUSTEE	0.75	Director	$0	$0	$0
LISA CAREY	TRUSTEE	0.75	Director	$0	$0	$0
JEFFREY CRAWFORD	TRUSTEE	0.75	Director	$0	$0	$0
MARCIA CRUZ-CORREA	TRUSTEE	0.75	Director	$0	$0	$0
KONSTANTIN DRAGNEV	TRUSTEE	0.75	Director	$0	$0	$0
JOHN ELLERTON	TRUSTEE	0.75	Director	$0	$0	$0
BRYAN FALLER	TRUSTEE	0.75	Director	$0	$0	$0
GINI FLEMING	TRUSTEE	0.75	Director	$0	$0	$0
RICHARD GOLDBERG	TRUSTEE	0.75	Director	$0	$0	$0
STEPHEN GRAZIANO	TRUSTEE	0.75	Director	$0	$0	$0
STEPHEN GRUBBS	TRUSTEE	0.75	Director	$0	$0	$0
CAROLYN HENDRICKS	TRUSTEE	0.75	Director	$0	$0	$0
CLIFFORD HUDIS	TRUSTEE	0.75	Director	$0	$0	$0
KELLY HUNT	TRUSTEE	0.75	Director	$0	$0	$0
HEIDI KLEPIN	TRUSTEE	0.75	Director	$0	$0	$0
JOHN LEONARD	TRUSTEE	0.75	Director	$0	$0	$0
ELLIS LEVINE	TRUSTEE	0.75	Director	$0	$0	$0
SUMITHRA MANDREKAR	TRUSTEE	0.75	Director	$0	$0	$0
GREGORY MASTERS	TRUSTEE	0.75	Director	$0	$0	$0
MICHAEL MORRIS	TRUSTEE (THRU MAR 2023)	0.75	Director	$0	$0	$0
ELECTRA PASKETT	TRUSTEE	0.75	Director	$0	$0	$0
JANE PERLMUTTER	TRUSTEE	0.75	Director	$0	$0	$0
STEVEN PIANTADOSI	TRUSTEE	0.75	Director	$0	$0	$0
DEBORAH SCHRAG	TRUSTEE	0.75	Director	$0	$0	$0
MICHAEL SCHWARTZ	TRUSTEE	0.75	Director	$0	$0	$0
W FRASER SYMMANS	TRUSTEE	0.75	Director	$0	$0	$0
MARIE WOOD	TRUSTEE	0.75	Director	$0	$0	$0
CARTER W DUFRANE	DIRECTOR OF CLINICAL TRIALS OPS	40.00	Key Emp	$244,744	$11,544	$256,288
ANDREA LORENA REINO	DIRECTOR OF CONTRACTS ADMIN	30.00	Highest	$194,554	$16,277	$210,831
LISA RENEE PITLER	SENIOR DIRECTOR, COMPLIANCE & HR	30.00	Highest	$236,054	$19,241	$255,295
SELINA CHOW	EXECUTIVE OFFICER	20.00	Highest	$253,348	$19,443	$272,791
JOSEPH GANNON	SR. PROJECT MANAGER	40.00	Highest	$188,432	$22,768	$211,200
AISHA AHMED	ASSOCIATE DIRECTOR	40.00	Highest	$203,013	$7,000	$210,013

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$41,500,086	$40,022,855	$118,132,432	$1,477,231
2022	$39,386,118	$42,878,871	$121,663,797	$-3,492,753
2021	$39,942,446	$40,313,273	$119,602,728	$-370,827
2020	$40,929,536	$37,088,250	$98,458,667	$3,841,286
2019	$50,808,918	$46,966,914	$101,700,356	$3,842,004
2018	$60,198,285	$51,579,227	$113,889,012	$8,619,058

ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY FOUNDATION